CA2-02: Identification of Prognostic Tumor Markers in HIV+ Diffuse Large B-cell Lymphoma

BACKGROUND/AIMS: About half of HIV+ diffuse large B-cell lymphoma (DLBCL) patients die within 2 years of diagnosis. Identification of prognostic tumor markers may assist clinical risk stratification and inform therapeutic developments. We examined if certain tumor markers in HIV+ DLBCL are associate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chao, Chun, Silverberg, Michael, Abrams, Donald, Haque, Reina, Zha, Hongbin, Martinez-Maza, Otoniel, McGuire, Michelle, Chi, Margaret, Castor, Brandon, Xu, Lanfang, Leyden, Wendy, Said, Jonathan
Formato: Artigo
Idioma:Inglês
Publicado em: Marshfield Clinic 2012
Assuntos:
Selected Abstracts-HMORN 2012: Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3421430/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2012.1100.ca2-02
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados